NYSE · CIK 0000075252
ACH OWENS & MINOR INC/VA/
Insider trading from SEC Form 4. Last filing 7 d ago. Close $0.43 on Oct 9, 2026, 0% from the 52-week low and -92% from the high.
In brief
OWENS & MINOR INC/VA/ (ACH) has 50 SEC Form 4 filings on file from 18 insiders, the latest filed on Oct 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
8 open-market trades have been scored at ACH. The newest: Coliseum Capital Management, LLC (10% owner) bought $8.1M of stock on Aug 12, 2025, filed Aug 14, 2025, scored 43 (moderate). The largest of the 8 shown: Coliseum Capital Management, LLC (10% owner) bought $27M on Feb 28, 2025, scored 38 (weak). 2 insiders sold within 14 days of each other around Nov 21, 2024.
8 Form 144 notices of planned sales are on file, the latest filed Sep 11, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at OWENS & MINOR INC/VA/, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Coliseum Capital Management, LLC owner buy | $8.1M 1,537,852 shares | +13% | +18% from low-66% from high | |
| 45Moderate | Coliseum Capital Management, LLC owner buy | $3.1M 410,000 shares | +4% | +25% from low-52% from high | |
| 45Moderate | Coliseum Capital Management, LLC owner buy | $4.3M 528,356 shares | +5% | +38% from low-47% from high | |
| 38Weak | Coliseum Capital Management, LLC owner buy | $27M 2,893,412 shares | +37% | - | |
| 17Weak | Jonathan A Leon EVP, Chief Financial Officer sell | $62k 5,282 shares | -4% | - | |
| 1Weak | Snehashish Sarkar other sell | $25k 2,055 shares | -4% | - | |
| 33Weak | Perry A Bernocchi EVP, CEO,. Patient Direct sell | $362k 19,302 shares | -11% | +60% from low-14% from high | |
| 27Weak | Alexander J Bruni EVP, CFO sell | $223k 12,668 shares | -23% | +42% from low-23% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 11, 2026 | Coliseum Capital Management, LLC 10% Stockholder | 10,726,759 13.95% of outstanding | $12M | Sep 11, 2026 | none |
| Nov 21, 2024 | Leon Jonathan A Officer | 5,282 0.01% of outstanding | $62k | Nov 21, 2024 | $119k |
| Nov 18, 2024 | Sarkar Snehashish Officer | 2,055 0.00% of outstanding | $25k | Nov 18, 2024 | none |
| Dec 20, 2023 | Leon Jonathan A Officer | 5,000 0.01% of outstanding | $107k | Dec 20, 2023 | $93k |
| Nov 21, 2023 | Bernocchi Perry A Officer | 19,302 0.03% of outstanding | $368k | Nov 21, 2023 | none |
| Nov 20, 2023 | Leon Jonathan A Officer | 5,000 0.01% of outstanding | $93k | Nov 20, 2023 | none |
| Nov 13, 2023 | Bruni Alexander J Officer | 12,668 0.02% of outstanding | $223k | Nov 10, 2023 | none |
| Nov 13, 2023 | Galloway Heath H Officer | 5,500 0.01% of outstanding | $97k | Nov 10, 2023 | none |
Transactions
The newest 50 of 59 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Kenneth Gardner-Smith President & CEO | AGrant or award Common Stock | +283,554 | $0.00 | $0 | 369,667 | 7 d ago |
| Sep 23, 2026 | Jonathan A Leon EVP & CFO | FTax withholding Common Stock | -4,265 | $0.85 | $3,625 | 286,268 | 19 d ago |
| May 18, 2026 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock | -1,822 | $2.91 | $5,302 | 166,306 | May 20, 2026 |
| May 15, 2026 | Edward A Pesicka President & CEO | FTax withholding Common Stock | -17,692 | $3.04 | $54k | 1,072,785 | May 19, 2026 |
| May 15, 2026 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock | -966 | $3.04 | $2,937 | 168,128 | May 19, 2026 |
| May 15, 2026 | Perry A Bernocchi EVP, Chief Operating Officer | FTax withholding Common Stock | -7,908 | $3.04 | $24k | 313,913 | May 19, 2026 |
| May 15, 2026 | Jonathan A Leon EVP & CFO | FTax withholding Common Stock | -1,770 | $3.04 | $5,381 | 290,533 | May 19, 2026 |
| May 14, 2026 | Mark A Beck director | AGrant or award Common Stock | +31,191 | $0.00 | $0 | 71,259 | May 18, 2026 |
| May 14, 2026 | Kenneth Gardner-Smith President & CEO | AGrant or award Common Stock | +31,191 | $0.00 | $0 | 86,113 | May 18, 2026 |
| May 14, 2026 | Gwendolyn M Bingham director | AGrant or award Phantom Stockderivative | +31,191 | $0.00 | $0 | 80,603 | May 18, 2026 |
| May 14, 2026 | Stephen W Klemash director | AGrant or award Common Stock | +31,191 | $0.00 | $0 | 90,242 | May 18, 2026 |
| May 14, 2026 | Teresa L. Kline director | AGrant or award Common Stock | +31,191 | $0.00 | $0 | 85,316 | May 18, 2026 |
| Mar 20, 2026 | Edward A Pesicka President & CEO | FTax withholding Common Stock | -58,945 | $2.03 | $120k | 1,090,477 | Mar 24, 2026 |
| Mar 20, 2026 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock | -9,347 | $2.03 | $19k | 169,094 | Mar 24, 2026 |
| Mar 20, 2026 | Perry A Bernocchi EVP, Chief Operating Officer | FTax withholding Common Stock | -20,841 | $2.03 | $42k | 321,821 | Mar 24, 2026 |
| Mar 20, 2026 | Jonathan A Leon EVP & CFO | FTax withholding Common Stock | -11,286 | $2.03 | $23k | 292,303 | Mar 24, 2026 |
| Mar 9, 2026 | Heath H Galloway EVP,General Counsel & CorpSecy | AGrant or award Common Stock | +61,437 | $0.00 | $0 | 178,441 | Mar 10, 2026 |
| Mar 9, 2026 | Perry A Bernocchi EVP, Chief Operating Officer | AGrant or award Common Stock | +108,696 | $0.00 | $0 | 342,662 | Mar 10, 2026 |
| Mar 9, 2026 | Jonathan A Leon EVP & CFO | AGrant or award Common Stock | +85,067 | $0.00 | $0 | 303,589 | Mar 10, 2026 |
| Nov 19, 2025 | Andrew G Long EVP, CEO P&HS | GGift Common Stock | -47,908 | $0.00 | $0 | 214,064 | Nov 20, 2025 |
| Sep 23, 2025 | Jonathan A Leon EVP & CFO | FTax withholding Common Stock | -4,265 | $5.40 | $23k | 218,522 | Sep 24, 2025 |
| Aug 12, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stock, par value $2 per share ("Common Stock")indirect: See Footnotes | +720,000 | $5.15 | $3.7M | 12,282,955 | Aug 14, 2025 |
| Aug 13, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +325,000 | $5.46 | $1.8M | 12,607,955 | Aug 14, 2025 |
| Aug 14, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +492,852 | $5.31 | $2.6M | 13,100,807 | Aug 14, 2025 |
| Jun 3, 2025 | Jennifer A Stone EVP, CHRO | FTax withholding Common Stock | -5,764 | $6.35 | $37k | 110,327 | Jun 4, 2025 |
| May 19, 2025 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock | -1,768 | $7.38 | $13k | 117,044 | May 20, 2025 |
| May 15, 2025 | Robert J Henkel director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 77,412 | May 16, 2025 |
| May 15, 2025 | Rita Johnson-Mills director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 54,125 | May 16, 2025 |
| May 15, 2025 | Stephen W Klemash director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 59,051 | May 16, 2025 |
| May 15, 2025 | Teresa L. Kline director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 54,125 | May 16, 2025 |
| May 15, 2025 | Jonathan A Leon EVP & CFO | FTax withholding Common Stock | -2,641 | $7.00 | $18k | 222,787 | May 16, 2025 |
| May 15, 2025 | Andrew G Long EVP, CEO P&HS | FTax withholding Common Stock | -19,081 | $7.00 | $134k | 261,972 | May 16, 2025 |
| May 15, 2025 | Michael Wayne Lowry SVP, Corporate Controller | FTax withholding Common Stock | -1,533 | $7.00 | $11k | 121,921 | May 16, 2025 |
| May 15, 2025 | Edward A Pesicka President & CEO | FTax withholding Common Stock | -35,208 | $7.00 | $246k | 1,149,422 | May 16, 2025 |
| May 15, 2025 | Snehashish Sarkar other | FTax withholding Common Stock | -4,336 | $7.00 | $30k | 108,586 | May 16, 2025 |
| May 15, 2025 | Carissa Rollins director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 53,902 | May 16, 2025 |
| May 15, 2025 | Mark A Beck director | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 40,068 | May 16, 2025 |
| May 15, 2025 | Perry A Bernocchi EVP, CEO,. Patient Direct | FTax withholding Common Stock | -13,394 | $7.00 | $94k | 233,966 | May 16, 2025 |
| May 15, 2025 | Gwendolyn M Bingham director | AGrant or award Phantom Stockderivative | +28,914 | $0.00 | $0 | 49,412 | May 16, 2025 |
| May 15, 2025 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock | -1,315 | $7.00 | $9,205 | 118,772 | May 16, 2025 |
| May 15, 2025 | Kenneth Gardner-Smith President & CEO | AGrant or award Common Stock | +28,914 | $0.00 | $0 | 54,922 | May 16, 2025 |
| Apr 8, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stock, par value $2 per share ("Common Stock")indirect: See Footnotes | +105,000 | $7.96 | $836k | 11,257,955 | Apr 10, 2025 |
| Apr 9, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +225,000 | $7.39 | $1.7M | 11,482,955 | Apr 10, 2025 |
| Apr 10, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +80,000 | $7.19 | $575k | 11,562,955 | Apr 10, 2025 |
| Apr 3, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stock, par value $2 per share ("Common Stock")indirect: See Footnotes | +160,000 | $8.53 | $1.4M | 10,784,599 | Apr 7, 2025 |
| Apr 4, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +128,356 | $8.14 | $1.0M | 10,912,955 | Apr 7, 2025 |
| Apr 7, 2025 | Coliseum Capital Management, LLC owner | POpen-market purchase Common Stockindirect: See Footnotes | +240,000 | $7.84 | $1.9M | 11,152,955 | Apr 7, 2025 |
| Mar 20, 2025 | Perry A Bernocchi EVP, CEO,. Patient Direct | FTax withholding Common Stock | -5,551 | $10.09 | $56k | 247,360 | Mar 24, 2025 |
| Mar 20, 2025 | Heath H Galloway EVP,General Counsel & CorpSecy | FTax withholding Common Stock10b5-1 | -2,734 | $10.09 | $28k | 120,087 | Mar 24, 2025 |
| Mar 3, 2025 | Perry A Bernocchi EVP, CEO,. Patient Direct | AGrant or award Common Stock | +123,391 | $0.00 | $0 | 252,911 | Mar 5, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Mark A Beckdirector
- Perry A BernocchiEVP, CEO,. Patient Direct
- Gwendolyn M Binghamdirector
- Alexander J BruniEVP, CFO
- Coliseum Capital Management, LLCowner, director
- Heath H GallowayEVP,General Counsel & CorpSecy
- Kenneth Gardner-SmithPresident & CEO
- Robert J Henkeldirector
- Rita Johnson-Millsdirector
- Stephen W Klemashdirector
- Teresa L. Klinedirector
- Jonathan A LeonEVP & CFO
- Andrew G LongEVP, CEO P&HS
- Michael Wayne LowrySVP, Corporate Controller
- Edward A PesickaPresident & CEO
- Carissa Rollinsofficer, director
- Snehashish Sarkarother
- Jennifer A StoneEVP, CHRO
Questions about ACH
Answered from the filings on this page, as of the latest one.
Are insiders buying ACH?
No. In the last 90 days no insider at OWENS & MINOR INC/VA/ bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ACH on the open market?
Coliseum Capital Management, LLC (10% owner) bought $8.1M of ACH on Aug 12, 2025 and filed the Form 4 on Aug 14, 2025. InsiderTell scored 43 (moderate).
How many insiders file Form 4 at OWENS & MINOR INC/VA/?
18 people have filed a Form 4 at OWENS & MINOR INC/VA/, among them Mark A Beck (director), Perry A Bernocchi (EVP, CEO,. Patient Direct), Gwendolyn M Bingham (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.